A Clinical Study for the ayurvedic management of Common Cold

A randomised open label comparative clinical study to evaluate the efficacy of parnayavani swarasa and haridra churna orally in the management of nava pratishyaya w.s.r. to Coryza

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025840

Enrollment

Registered

2020-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Parnayavani swarasa orally: Dose - 12 ML Frequency - BD Duration - 7 days Follow-up - 8th DAY 14th DAY 21st DAY Control Intervention1: Haridra churna with lukewarm water orally: Dos

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects presenting with the symptoms of Nava Pratishyaya with an onset of not more than 3 days. 2. Subjects aged between 18 to 50 years.

Exclusion criteria

Exclusion criteria: 1. Coryza associated with malignant lesions, Leprosy, TB and other Specific Acute Infective Lesions. 2. Disease due to Dental infection, Trauma, Nasal polyp, Oro-antral fistula, Fistula of Frontonasal duct, Deviated nasal septum

Design outcomes

Primary

Measure	Time frame
Reduction in absolute eosonophil countTimepoint: 8th day, 14th day, 21st day	—

Secondary

Measure	Time frame
Reduction in Jackson scoreTimepoint: 8th day, 14th day, 21st day	—

Countries

India

Contacts

Public ContactDr Naveen B S

Sri Sri College of Ayurvedic Science and Research Hospital

navs009@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026